Showing results (131-140 of 426) with videos related to
Sort By:
Pageof 43
International Journal of Colorectal Disease|February 15, 2026
Utilisation of intramuscular and intermuscular fat to develop a new skeletal muscle grading score which can predict treatment outcomes for locally advanced rectal cancerAlex Besson, Ke Cao, Michael Rouse, et al.Journal of Surgical Oncology|September 5, 2024
Accuracy of Baseline Magnetic Resonance Imaging for Staging Rectal Cancer Patients Proceeding Directly to SurgeryElasma Milanzi, Rachel M Pelly, Ian P Hayes, et al.Pharmacoeconomics|April 23, 2020
Health Economic Models for Metastatic Colorectal Cancer: A Methodological ReviewKoen Degeling, Martin Vu, Hendrik Koffijberg, et al.Asia-Pacific Journal of Clinical Oncology|January 3, 2013
Pharmaco-economic analysis of direct medical costs of metastatic colorectal cancer therapy with XELOX or modified FOLFOX-6 regimens: implications for health-care utilization in AustraliaGiao Tran, Stephen P Hack, Annette Kerr, et al.Diseases of the Colon and Rectum|September 8, 2016
Impact of Surgical Complications Following Resection of Locally Advanced Rectal Adenocarcinoma on Adjuvant Chemotherapy Delivery and Survival OutcomesMurtaza Jamnagerwalla, Rebecca Tay, Malcolm Steel, et al.ANZ Journal of Surgery|July 3, 2004
Carcinoma of the anal canal: a local experience and review of the literatureShirley Wong, Peter Gibbs, Michael Chao, et al.ANZ Journal of Surgery|June 4, 2005
Preoperative chemotherapy and radiotherapy for locally advanced rectal cancerMichael Chao, Peter Gibbs, Joe Tjandra, et al.ANZ Journal of Surgery|March 27, 2013
Second primary colorectal cancer in the era of prevalent screening and imagingSusie Bae, Muslim Asadi, Ian Jones, et al.Proceedings of the National Academy of Sciences of the United States of America|March 21, 2008
Cytosine methylation profiling of cancer cell linesMathias Ehrich, Julia Turner, Peter Gibbs, et al.BMC Cancer|December 10, 2014
Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX studyPeter Gibbs, Val Gebski, Mark Van Buskirk, et al.Pageof 43